| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Kala Pharmaceuticals (NASDAQ:KALA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM.
Here's what investors need to know about the announcement.
Kala Pharmaceuticals missed estimated earnings by 54.65%, reporting an EPS of $-6.99 versus an estimate of $-4.52.
Revenue was down $1.37 million from the same period last year.
Last quarter the company beat on EPS by $0.09 which was followed by a 64.7% increase in the share price the next day.
To track all earnings releases for Kala Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: KALA
